1. Home
  2. FLGT vs AIO Comparison

FLGT vs AIO Comparison

Compare FLGT & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • AIO
  • Stock Information
  • Founded
  • FLGT 2011
  • AIO 2019
  • Country
  • FLGT United States
  • AIO United States
  • Employees
  • FLGT N/A
  • AIO N/A
  • Industry
  • FLGT Medical Specialities
  • AIO Finance/Investors Services
  • Sector
  • FLGT Health Care
  • AIO Finance
  • Exchange
  • FLGT Nasdaq
  • AIO Nasdaq
  • Market Cap
  • FLGT 683.5M
  • AIO 760.3M
  • IPO Year
  • FLGT 2016
  • AIO N/A
  • Fundamental
  • Price
  • FLGT $18.34
  • AIO $23.79
  • Analyst Decision
  • FLGT Hold
  • AIO
  • Analyst Count
  • FLGT 1
  • AIO 0
  • Target Price
  • FLGT $22.00
  • AIO N/A
  • AVG Volume (30 Days)
  • FLGT 298.0K
  • AIO 141.5K
  • Earning Date
  • FLGT 11-08-2024
  • AIO 01-01-0001
  • Dividend Yield
  • FLGT N/A
  • AIO 9.05%
  • EPS Growth
  • FLGT N/A
  • AIO N/A
  • EPS
  • FLGT N/A
  • AIO N/A
  • Revenue
  • FLGT $277,761,000.00
  • AIO N/A
  • Revenue This Year
  • FLGT N/A
  • AIO N/A
  • Revenue Next Year
  • FLGT $16.00
  • AIO N/A
  • P/E Ratio
  • FLGT N/A
  • AIO N/A
  • Revenue Growth
  • FLGT N/A
  • AIO N/A
  • 52 Week Low
  • FLGT $16.56
  • AIO $15.09
  • 52 Week High
  • FLGT $30.68
  • AIO $20.25
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 41.26
  • AIO 46.79
  • Support Level
  • FLGT $19.25
  • AIO $24.15
  • Resistance Level
  • FLGT $21.36
  • AIO $24.99
  • Average True Range (ATR)
  • FLGT 0.88
  • AIO 0.55
  • MACD
  • FLGT -0.11
  • AIO -0.20
  • Stochastic Oscillator
  • FLGT 0.66
  • AIO 21.85

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.

Share on Social Networks: